Forecast: Beta Blocking Medicine Use in Italy

In 2023, the usage of beta-blocking medication in Italy stood at a specific data point. The forecast from 2024 to 2028 shows a gradual increase in the Defined Daily Dosage (DDD) per thousand persons per day from 55.0 to 56.9. Year-on-year increases indicate consistent growth, with percentages slightly rising each year. Over the forecast period, the Compound Annual Growth Rate (CAGR) is stable, demonstrating a steady upward trend, reflecting a growing reliance on beta-blockers in managing cardiovascular conditions.

Future trends to watch for include technological advancements in personalized medicine, which may influence beta-blocker prescriptions. Additionally, demographic shifts and healthcare policies could impact usage rates, as could emerging research on alternative treatments or new indications for beta-blockers.